retatrutide phase 2 results weight loss UK | The Ultimate Guide | Latest Trial Triple hormone receptor agonist retatrutide

Kellerer, M., Kaltoft, M

Neuroimaging studies indicate decreased activity in reward regions when exposed to food signals, implying an alteration in hedonic eating behaviour (Devoto et al

Common microdosing approaches The following are the common microdosing approaches: Sustained low dose: Some individuals remain indefinitely on the initial starter dose, such as 0.25 mg of semaglutide weekly, and never exceed this dose

Because it engages all three, retatrutide is often described as a triple agonist. For comparison, tirzepatide is a dual agonist (GLP-1 and GIP) and semaglutide is a single agonist (GLP-1)

Recommended storage is 2C to 8C under refrigeration

If you are struggling with the side effects of a specific dose or wondering if a different medication formatlike oral semaglutide or oral tirzepatidemight be a better fit, a personalized consultation can provide the answers you need